Loading…
Loading…
NTUS (Natus Medical Incorporated) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
NEW YORK , June 23, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: U.S. Well Services, Inc. (NASDAQ: USWS)'s sale to ProFrac Holding Corp. Under the terms of the merger agreement, USWS shareholders will receive 0.0561 shares of ProFrac Class A common stock for each share of USWS Class A common stock they own. If you are a USWS shareholder, click here to learn more about your rights and options.
Here is how Natus Medical (NTUS) and Option Care (OPCH) have performed compared to their sector so far this year.
NEW YORK , April 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: American Campus Communities, Inc. (NYSE: ACC)'s sale to Blackstone related entities for $65.47 per share in cash. If you are an American Campus shareholder, click here to learn more about your rights and options.
Natus Medical Incorporated (NASDAQ: NTUS) shares are up 25% after the medical device solutions provider for screening, diagnosing and treating disorders that affect the brain sensory nervous systems ad neural pathways signed definitive agreement to be bought by ArchiMed affiliate for $1.2 billion. Shareholders to receive 33.5 per share Stockholders will get $33.50 in cash for […] The post Here is why Natus Medical is up 25% appeared first on Invezz.
A suitor wants to take the company private.
Natus Medical is being acquired by ArchiMed for a 29% premium.
Natus Medical Inc (NASDAQ: NTUS) will be acquired by ArchiMed, an investment firm focused exclusively on the healthcare industry, for approximately $1.2 billion. Natus shareholders will receive $33.50 in cash for each share, representing a 29% premium to the closing price of the.
Natus Medical Inc. NTUS, +0.58% announced Monday a deal to be acquired in a deal valued at $1.2 billion by an affiliate of investment firm ArchiMed. Natus Medical's stock was still halted for news until 7:30 a.m.
No recent filings indexed.